A Case Report of Alcohol-Associated Cirrhosis Treated with Cheongganhaeju-tang

Abstract

Objectives: This study identified the effects of Korean medicine treatment on a patient with alcohol-associated cirrhosis.Methods: A 50-year-old male with alcohol-associated cirrhosis was treated with Cheongganhaeju-tang from 10 November 2023 to 18 January 2024 to reduce fatigue, dyspepsia, anorexia, and weight loss and to improve laboratory findings, such as liver enzymes. We observed changes in the patient’s symptoms and laboratory findings during a treatment period of approximately 2 months.Results: With Cheongganhaeju-tang treatment, serum levels of liver enzymes remained stable, clinical symptoms improved, and alcohol cravings decreased.Conclusion: This case points to Cheongganhaeju-tang as a therapeutic option to manage alcohol-associated cirrhosis.